Triglyceride

There are 4,511 papers on triglyceride in aging research: 931 trials and 2,336 observational studies in people, 519 in animals, 11 in cells, 649 reviews.

Biomarker

4,511 papers study it1,957 more mention it1,061 findings

MeSH

593 new papers in 30 daysSee all 6,469 papers on triglyceride

At a glance

Higher triglycerides are linked with incident frailty in a human cohort preprint and with sarcopenia in a study of Korean postmenopausal women. Human observational studies also link triglycerides with epigenetic aging measures. Human trials report reductions with exercise and several dietary interventions, whereas a high-carbohydrate diet trial reports increases.

1,061 findings in 948 papers from 1984 to 2026, 171 of them since April 2026

“The initial GRS31 explained 50.1% of the variance in plasma TG levels during the intervention”
Update of a Genetic Risk Score Predictive of the Plasma Triglyceride Response to an Omega-3 Fatty Acid Supplementation in the FAS StudyNutrients2023doi:10.3390/nu15051156
  • Human trial931
  • Humans2,336
  • Animals438
  • Model organisms81
  • Cells11
  • In silico18

Interventions

236

Exercise

downin humans14no changein flies1no changein humans1downin mice1−20%

17 studies
  1. Exercise decreases triglyceride in humans (MD -0.149 mmol/L (95% CI -0.199 to -0.099)).

    “The random-effects synthesis of all exercise modalities yielded an MD of −0.149 mmol/L (95% CI −0.199 to −0.099; τ = 0.106 mmol/L; I2 = 7.8%).”

    Human trialn = 4,483

    Dose-Response Relationships Between Exercise Modalities and Triglyceride Reduction in Adults: A Systematic Review and Model-Based Network Meta-Analysis

    Metabolites

  2. Exercise decreases triglyceride in humans (-0.149 mmol/L (95% CI 0.099-0.199)).

    “Exercise reduced TG by 0.149 mmol/L, on average (95% CI 0.099-0.199)”

    Human trial

    Dose-Response Relationships Between Exercise Modalities and Triglyceride Reduction in Adults: A Systematic Review and Model-Based Network Meta-Analysis

    Metabolites

  3. Exercise decreases triglyceride in humans (Hedges’ g = −0.45).

    “improved lipid metabolism and fat distribution, reducing LDL-C (Hedges’ g = −0.36, p = 0.001), TG (Hedges’ g = −0.45, p < 0.001”

    Human trial6 to 52 weeksn = 2,578

    Effects of exercise intervention on glucose and lipid metabolism in patients with type 2 diabetes mellitus complicated by non-alcoholic fatty liver disease: a three-level meta-analysis

    Frontiers in nutrition

  4. Exercise decreases triglyceride in patients with type 2 diabetes mellitus complicated by non-alcoholic fatty liver disease (Hedges' g = -0.45, p < 0.001).

    “TG (Hedges' g = -0.45, p < 0.001), ALT (Hedges' g = -0.41, p < 0.001), AST (Hedges' g = -0.38, p < 0.001)”

    Human trialin patients with type 2 diabetes mellitus complicated by non-alcoholic fatty liver disease

    Effects of exercise intervention on glucose and lipid metabolism in patients with type 2 diabetes mellitus complicated by non-alcoholic fatty liver disease: a three-level meta-analysis

    Frontiers in nutrition

  5. Exercise decreases triglyceride in humans (overweight and obese postmenopausal women) (d = 0.75, p = 0.043).

    “TG levels (p = 0.043; d = 0.75)”

    Human trialoverweight and obese postmenopausal women12-weeksfemalesn = 11

    Short-term effects of a 12-week Zumba program on thyroid and cardiometabolic markers in overweight/obese postmenopausal women: A randomized pilot study

    Clinics (Sao Paulo, Brazil)

  6. Exercise decreases triglyceride in humans among White participants in the intervention arm at the fifth timepoint (β=.38, p<.001).

    “triglycerides(β=.38, p<.001) only among White participants”

    Human trialamong White participants in the intervention arm at the fifth timepointtwo yearsn = 1,600

    THE IMPACT OF THE LIFE TRIAL ON CARDIOVASCULAR HEALTH: RACIAL DISPARITIES IN LIFESTYLE FACTOR IMPROVEMENT

    GSA 2024 abstract

  7. Exercise decreases triglyceride in humans (-20.0%).

    “and decreased triglycerides (-20.0% and -77.8%).”

    Human trial12 weeksfemalesn = 57

    Biopsychosocial Effects of a Conventional Exercise Program and Culturally Relevant Activities in Older Women From Mozambique

    Journal of physical activity & health

  8. Exercise decreases triglyceride in humans.

    “Exercise training decreased blood pressure and triglyceride levels”

    Human trialwhole blood14 wkfemalesn = 45

    Exercise training modifies the whole blood DNA methylation profile in middle-aged and older women

    Journal of applied physiology (Bethesda, Md. : 1985)

  9. Exercise decreases triglyceride in humans (triglycerides p = 0.011, insulin p = 0.002).

    “significant decreases in blood glucose (p = 0.052), triglycerides (p = 0.011), insulin (p = 0.002)”

    Human trialsix-monthfemales

    A Non-Randomized Combined Program of Walking and Low-Load Resistance Exercise Improves Cognitive Function and Cardiometabolic Risk Factors in Community-Dwelling Elderly Women

    Healthcare (Basel, Switzerland)

  10. Exercise decreases triglyceride in humans (post-HFHC) (P < 0·05).

    “TAG levels increased to a larger magnitude in OA (Δ∼61 ± 31 %) compared to YA (Δ∼37 ± 34 %, P < 0·001), which were attenuated in EX compared to NE (P < 0·05) independent of age.”

    Human trialpost-HFHC12 hours prior to HFHC

    Acute exercise improves glucose and TAG metabolism in young and older adults following high-fat, high-carbohydrate meal intake

    The British journal of nutrition

All 19

More on Exercise

Tirzepatide

downin humans13upin humans1

14 studies
  1. Tirzepatide decreases triglyceride in a patient with severe hypertriglyceridemia and type 2 diabetes (from 335 mg/dL to 85 mg/dL at 12 months).

    “triglycerides normalized to 137 mg/dL at 3 months and 85 mg/dL at 12 months”

    Human trialin a patient with severe hypertriglyceridemia and type 2 diabetes12 monthsfemalesn = 1

    Tirzepatide in recurrent hypertriglyceridemia-mediated pancreatitis and type 2 diabetes: a case report

    Cardiovascular diabetology. Endocrinology reports

  2. Tirzepatide decreases triglyceride in humans (versus liraglutide).

    “All tirzepatide doses were associated with statistically greater improvements in triglycerides and diastolic blood pressure versus liraglutide”

    Human trialversus liraglutide5, 10 and 15 mg

    Comparison of Clinical Efficacy and Safety of Tirzepatide, Liraglutide and Semaglutide in Patients with Obesity and Without T2D: A Bayesian Network Meta-Analysis of Randomised Controlled Trials

    Advances in therapy

  3. Tirzepatide decreases triglyceride in humans across all body weight reduction subgroups (15-48% reduction).

    “Improvements in waist circumference (3.2-35.3 cm reduction), HbA1c (0.30-0.76% reduction) and triglycerides (15-48% reduction) were observed among all body weight reduction subgroups”

    Human trialacross all body weight reduction subgroupspooled 5, 10 and 15 mg176 weeksn = 458

    Improvements in Cardiometabolic Risk Factors by Body Weight Reduction with Tirzepatide in Adults with Obesity and Prediabetes: A Post Hoc Analysis of the 3-year SURMOUNT-1 study

    AHA Scientific Sessions 2025 abstract

  4. Tirzepatide decreases triglyceride in partial lipodystrophy, despite discontinuation of fenofibrate (211 to 73 mg/dL).

    “Triglyceride decreased from 211 mg/dL to 73 mg/dL, despite discontinuation of fenofibrate.”

    Human trialin partial lipodystrophy, despite discontinuation of fenofibratefemalesn = 1

    MON-694 Resolving the Metabolic Puzzle, Tirzepatide's Multifaceted Benefits in Partial Lipodystrophy

    ENDO 2025 abstract

  5. Tirzepatide decreases triglyceride in humans (primarily after weight reductions greater than 10%).

    “Improvements in levels of triglycerides, high-density lipoprotein (HDL) cholesterol, low-density lipoprotein cholesterol, and non-HDL cholesterol were primarily observed only after weight reductions greater than 10%.”

    Human trialprimarily after weight reductions greater than 10%5, 10, or 15 mg once weekly72 weeks

    Improvements in Cardiometabolic Risk Factors by Weight Reduction: A Post Hoc Analysis of Adults With Obesity Randomly Assigned to Tirzepatide

    Annals of internal medicine

  6. Tirzepatide decreases triglyceride in humans (indirect comparison versus semaglutide 2.4 mg via placebo).

    “statistically significant improvements in several cardiometabolic risk factors, including waist circumference, fasting plasma glucose and triglycerides”

    Human trialindirect comparison versus semaglutide 2.4 mg via placebo15 mg once weekly

    Indirect comparative efficacy and safety of tirzepatide 10 and 15 mg versus semaglutide 2.4 mg for the management of obesity and overweight in patients with type 2 diabetes

    Diabetes, obesity & metabolism

  7. Tirzepatide decreases triglyceride in humans (early-onset type 2 diabetes, similar to later-onset type 2 diabetes) (-26% vs. -24%).

    “triglycerides (-26% vs. -24%)”

    Human trialearly-onset type 2 diabetes, similar to later-onset type 2 diabetesweek 40

    Early-Onset Type 2 Diabetes and Tirzepatide Treatment: A Post Hoc Analysis From the SURPASS Clinical Trial Program

    Diabetes care

  8. Tirzepatide increases triglyceride in humans (versus placebo or other antidiabetic medications).

    “triglyceride (TG) (P < 0.01), and WC (P < 0.01) changes from baseline”

    Human trialversus placebo or other antidiabetic medications5, 10 and 15 mg once weekly

    Effect of the Dual Glucose‐Dependent Insulinotropic Peptide/Gulcagon‐like Peptide 1 Receptor Agonist Tirzepatide on Lipid Profile and Waist Circumference: A Systematic Review and Meta‐analysis

    Clinical therapeutics

  9. Tirzepatide decreases triglyceride in a patient with T2DM and heterozygous lipoprotein lipase deficiency (58% reduction at 2 months; 86% reduction at 5 months).

    “Tirzepatide caused a significant decrease in the TG level in a patient with CM, T2DM, and HeLPL.”

    Human trialin a patient with T2DM and heterozygous lipoprotein lipase deficiencytitrated to 15 mg/week5 monthsmalesn = 1

    Tirzepatide Therapy in a Patient with Type 2 Diabetes Mellitus, Chylomicronemia, and Heterozygosity for Lipoprotein Lipase Deficiency

    AACE clinical case reports

  10. Tirzepatide decreases triglyceride in humans (compared with baseline, dulaglutide, and placebo).

    “triglycerides and diglycerides were lowered significantly compared to baseline, dulaglutide, and placebo”

    Human trialcompared with baseline, dulaglutide, and placebo26 weeksn = 259

    Effects of Tirzepatide, a Dual GIP and GLP-1 RA, on Lipid and Metabolite Profiles in Subjects With Type 2 Diabetes

    The Journal of clinical endocrinology and metabolism

All 14

More on Tirzepatide

High-intensity interval training

downin humans9downin rats1−21% to −4.8%

10 studies
  1. High-intensity interval training decreases triglyceride in humans (-0.225, -0.392 to -0.059).

    “In the modality network, CE had the largest average estimate (MD −0.255, 95% CI −0.355 to −0.156), followed by HIIT (−0.225, −0.392 to −0.059) and AE (−0.130, −0.185 to −0.074); RT was inconclusive (−0.057, −0.153 to 0.039).”

    Human trial

    Dose-Response Relationships Between Exercise Modalities and Triglyceride Reduction in Adults: A Systematic Review and Model-Based Network Meta-Analysis

    Metabolites

  2. High-intensity interval training decreases triglyceride in humans (MD -0.225 mmol/L).

    “followed by HIIT (-0.225) and AE (-0.130)”

    Human trial

    Dose-Response Relationships Between Exercise Modalities and Triglyceride Reduction in Adults: A Systematic Review and Model-Based Network Meta-Analysis

    Metabolites

  3. High-intensity interval training decreases triglyceride in humans (-4.8%).

    “triglycerides decreased (evening: -4.8%, p ≤ 0.01).”

    Human trialserumfemales

    Metabolic impact of exercise timing: Myonectin dynamics in overweight and obese postmenopausal women following high-intensity interval training

    Maturitas

  4. High-intensity interval training decreases triglyceride in humans (overweight or obesity).

    “Regarding circulating parameters, CONC and HIIT significantly (P < 0.05) reduced circulating triglycerides, total cholesterol, and LDL-cholesterol”

    Human trialoverweight or obesity12 weeksfemalesn = 45

    Effects of high-intensity interval training and concurrent training on body composition and metabolic profile in postmenopausal women with overweight or obesity: a clinical trial

    Exploration of Endocrine and Metabolic Diseases

  5. High-intensity interval training decreases triglyceride in EWG (-21.3%).

    “HIIT resulted in a decrease in BMI (−1.62%; p = 0.015), BF (−1.59%; p = 0.021), TC (−11.8%; p = 0.026), TG (−21.3%; p = 0.023), and HOMA-IR (−31.5%; p = 0.043) in EWG, but no significant changes were observed in NWG.”

    Human trialin EWG8 consecutive weeksn = 9

    Effects of High-Intensity Interval Training on Selected Adipokines and Cardiometabolic Risk Markers in Normal-Weight and Overweight/Obese Young Males-A Pre-Post Test Trial

    Biology

  6. High-intensity interval training decreases triglyceride in EWG only (-21.3% (p = 0.023)).

    “triglycerides (−21.3%; p = 0.023)”

    Human trialin EWG only8 weeksmalesn = 9

    Effects of High-Intensity Interval Training on Selected Adipokines and Cardiometabolic Risk Markers in Normal-Weight and Overweight/Obese Young Males-A Pre-Post Test Trial

    Biology

  7. High-intensity interval training decreases triglyceride in humans (type 2 diabetes mellitus; compared with non-exercise control) (MD -0.48 mmol/L, 95% CrI -0.67 to -0.30).

    “high-intensity interval training (HIIT) produced the most favorable estimate for TG reduction (MD = -0.48 mmol/L, 95% CrI: -0.67, -0.30; SUCRA = 92.53%)”

    Reviewtype 2 diabetes mellitus; compared with non-exercise control

    Comparative effects of different exercise modalities and doses on lipid metabolism in patients with type 2 diabetes mellitus: a systematic review with Bayesian dose-response network meta-analysis

    Frontiers in endocrinology

  8. High-intensity interval training decreases triglyceride in humans (MD -0.23 mmol/L, 95% CrI -0.44 to -0.03).

    “HIIT (MD: -0.23 mmol/L, 95% CrI: -0.44 to -0.03), AE (MD: -0.20 mmol/L, 95% CrI: -0.27 to -0.13), and CE (MD: -0.17 mmol/L, 95% CrI: -0.31 to -0.03) significantly reduced TG relative to CON”

    Reviewhigh-intensity interval trainingfemalesn = 2,046

    Exercise dose and triglyceride reduction in postmenopausal women: a systematic review and model-based network meta-analysis

    Frontiers in physiology

  9. High-intensity interval training decreases triglyceride in humans (individuals with overweight and obesity) (SMD = -0.40).

    “and reduced TG (SMD = -0.40) compared to nonexercising controls.”

    Reviewindividuals with overweight and obesity

    Effects and Dose-Response Relationship of High-Intensity Interval Training on Cardiometabolic Risk in Individuals With Overweight and Obesity: A Systematic Review and Meta-Analysis

    Obesity reviews : an official journal of the International Association for the Study of Obesity

  10. High-intensity interval training decreases triglyceride in diet-induced obese rats.

    “HHT rats displayed significantly lower plasma triglyceride levels than H and HMT rats.”

    Animalsin diet-induced obese rats8 weekmalesn = 8

    High-intensity intermittent training promotes adipose tissue browning via the IL-27/p38 MAPK-PGC-1α signaling pathway in diet-induced obese rats

    Frontiers in physiology

All 12

More on High-intensity interval training

Caloric restriction

downin humans4downin mice2downin dogs1downin rats1+1−99%

9 studies
  1. Caloric restriction decreases triglyceride in humans (up to 99.1%).

    “concentration of several triglyceride (TAG) species decreased up to 98.3% and 99.1% for KD and LCD, respectively, while these reductions were only significant for LCD”

    Human trialshort-term

    Short-term effect of Ketogenic diet and Low-calorie diet on Ketometabolism and lipid metabolism

    The Journal of nutritional biochemistry

  2. Caloric restriction decreases triglyceride in humans (-12.9% vs -13.1%).

    “Plasma triglycerides decreased by 12.9% in the CR group and 13.1% in the CR + Ex group (p ≤ 0.01”

    Human trial6-monthfemalesn = 102

    Effects of caloric restriction and exercise-induced weight loss on physiological dysregulation in postmenopausal women: The mediating role of fat mass and adipose tissue distribution

    The journal of nutrition, health & aging

  3. Caloric restriction decreases triglyceride in humans (inactive overweight or obese) (from 1.70 ± 0.77 to 1.48 ± 0.76 mmol/L).

    “triglycerides (from 1.70 ± 0.77 to 1.48 ± 0.76 mmol/L)”

    Human trialinactive overweight or obese6-monthfemalesn = 102

    Effects of caloric restriction and exercise-induced weight loss on physiological dysregulation in postmenopausal women: The mediating role of fat mass and adipose tissue distribution

    The journal of nutrition, health & aging

  4. Caloric restriction decreases triglyceride in humans.

    “This normalization implies that both calorie-restricted and low-starch diets were equally effective in modulating triglyceride levels, irrespective of baseline differences.”

    Human trial12 weeksfemalesn = 67

    Impact of a 12-Week Dietary Intervention on Adipose Tissue Metabolic Markers in Overweight Women of Reproductive Age

    International journal of molecular sciences

  5. Caloric restriction decreases triglyceride in dogs (obese dogs) (126.6 to 78.4 mg/dl (p < 0.01)).

    “In obese group, hypertriglyceridaemia normalised (126.6 to 78.4 mg/dl; p < 0.01)”

    Animalsobese dogs150 daysn = 10

    Metabolic and urinary profiles in normal-weight, overweight and obese dogs: clinical response to an individualised weight loss programme

    Research in veterinary science

  6. Caloric restriction decreases triglyceride in rhesus monkeys.

    “higher levels of diglycerides (DGs) and triglycerides (TGs), each of which was opposed by CR”

    Animalsplasma30% restricted

    Aging-linked systemic lipid signature is reprogrammed by caloric restriction in rhesus monkeys

    Molecular systems biology

  7. Caloric restriction decreases triglyceride in mice (ApoE/LDLr-/-).

    “TAG levels significantly decreased in both young and adult CR mice.”

    AnimalsApoE/LDLr-/-males

    Negative Impact of Caloric Restriction on Atherosclerosis in Young ApoE/LDLr -/- Mice

    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology

  8. Caloric restriction decreases triglyceride in rats (late-onset CR from 21st to 24th month vs ad libitum feeding).

    “late-onset CR reduces body weight, visceral adipose tissue and liver mass, and triglyceride levels when compared to old animals on AL diet”

    Animalslate-onset CR from 21st to 24th month vs ad libitum feedinglate-onset, 60% of AL daily intake60% of AL daily intake21st to 24th monthmales

    Late-Onset Calorie Restriction Improves Lipid Metabolism and Aggravates Inflammation in the Liver of Old Wistar Rats

    Frontiers in nutrition

  9. Caloric restriction decreases triglyceride in db/db mice with type 2 diabetes mellitus.

    “reductions of hepatic and plasma triglycerides”

    Animalsin db/db mice with type 2 diabetes mellitus12 weeksmales

    The daily caloric restriction and alternate-day fasting ameliorated lipid dysregulation in type 2 diabetic mice by downregulating hepatic pescadillo 1

    European journal of nutrition

  10. Caloric restriction decreases triglyceride in humans (hypertriglyceridemia).

    “Macronutrient distribution changes such as fat or protein, low-carbohydrate diets, and caloric restriction seem to be effective strategies in reducing TG levels.”

    Reviewhypertriglyceridemia

    The Effect of Dietary Interventions on Hypertriglyceridemia: From Public Health to Molecular Nutrition Evidence

    Nutrients

More on Caloric restriction

Resveratrol

downin humans4no changein humans2downin F. catus1downin mice1+1

9 studies
  1. Resveratrol decreases triglyceride in randomized controlled trials.

    “RES significantly reduced triglycerides (TG)”

    Reviewin randomized controlled trialsn = 337

    Anti-inflammatory mechanism of resveratrol's Triglyceride-lowering effect in hyperlipidemia: a meta-analysis integrated network pharmacology and molecular dynamics simulation

    Clinical and experimental medicine

  2. Resveratrol decreases triglyceride in obese and overweight cats.

    “Plasma triglyceride, free fatty acids, and serum amyloid A (SAA) concentrations and lactate dehydrogenase (LDH) activities decreased”

    Animalsin obese and overweight cats4 weeks

    Effect of resveratrol supplementation on lipid metabolism in healthy and obese cats

    Frontiers in veterinary science

  3. Resveratrol showed no clear effect on triglyceride in individuals with obesity or overweight (SMD = 0.11, 95%CI [-0.14, 0.35], P = 0.39).

    “Resveratrol showed no significant impact on triglycerides (SMD = 0.11, 95%CI [-0.14, 0.35], P = 0.39, I2 = 0 %)”

    Reviewin individuals with obesity or overweight4-week

    Effect of resveratrol supplementation on metabolic risk markers and anthropometric parameters in individuals with obesity or overweight: A systematic review and meta-analysis of randomized controlled trials

    Obesity pillars

  4. Resveratrol decreases triglyceride in humans (SMD = -0.14 mg/dl, 95 % CI: -0.24, -0.03; p = 0.001).

    “resveratrol supplementation was effective in reducing serum triglyceride (TG) (SMD = -0.14 mg/dl, 95 % CI: -0.24, -0.03; p = 0.001)”

    Review

    Efficacy of resveratrol supplementation on lipid profile parameters: An umbrella of meta-analysis

    Prostaglandins & other lipid mediators

  5. Resveratrol decreases triglyceride in HFD/STZ-induced diabetic rats (P < 0.01).

    “RSV treatment significantly reduced liver/body weight ratio (L/W, P < 0.05), FBG (P < 0.01) and serum concentrations of total cholesterol (TC, P < 0.05), triglycerides (TG, P < 0.01) and low-density lipoprotein-cholesterol (LDL-C, P < 0.05)”

    Animalsin HFD/STZ-induced diabetic rats30 mg/kg/d12 weeksmales

    Resveratrol Regulates Glucose and Lipid Metabolism in Diabetic Rats by Inhibition of PDK1/AKT Phosphorylation and HIF-1α Expression

    Diabetes, metabolic syndrome and obesity : targets and therapy

  6. Resveratrol decreases triglyceride in humans (meta-analysis of RCTs).

    “triglyceride (TG) (Mean difference = −856; 95%CI: −12.37, −4.75, p < 0.001)”

    Reviewmeta-analysis of RCTs

    The Effect of Resveratrol on Blood Lipid Profile: A Dose-Response Meta-Analysis of Randomized Controlled Trials

    Nutrients

  7. Resveratrol showed no clear effect on triglyceride in humans (type 2 diabetes) (WMD: -4.49 mg/dL, 95% CI: -24.23, 15.25).

    “did not improve waist circumference (WMD: 0.05 cm, 95% CI: -1.77, 1.88; P=0.95), triglyceride levels (WMD: -4.49 mg/dL, 95% CI: -24.23, 15.25; P=0.66)”

    Reviewtype 2 diabetesn = 1,151

    Effects of Resveratrol on Metabolic Indicators in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis

    International journal of clinical practice

  8. Resveratrol decreases triglyceride in humans.

    “Studies that composed Cluster II were characterized by a mean dose of 454.14 mg/day for 74.21 days and showed higher reduction of triglyceride concentration and blood pressure”

    Review454.14 mg/day74.21 days

    Effect of resveratrol supplementation on biomarkers associated with atherosclerosis in humans

    Complementary therapies in clinical practice

  9. Resveratrol decreases triglyceride in high fat diet-fed mice.

    “while RSV reverted TGs to control level but not weight or cholesterol”

    Animalsin high fat diet-fed mice

    Resveratrol Regulates the Expression of Genes Involved in CoQ Synthesis in Liver in Mice Fed with High Fat Diet

    Antioxidants (Basel, Switzerland)

More on Resveratrol

Resistance training

downin humans5no changein humans3

8 studies
  1. Resistance training showed no clear effect on triglyceride in humans (pregnancy).

    “RE lowered FBG and TyG but did not impact TG.”

    Human trialpregnancyfrom 16 to 36 weeks gestationfemalesn = 57

    Prenatal Exercise Mode Shapes Maternal Glycemia and Insulin Resistance across Pregnancy

    ADA Scientific Sessions 2026 abstract

  2. Resistance training decreases triglyceride in older women with depressive disorders (-17.1 [-43.0; -8.8]).

    “In the training group with depressive disorders, it was observed an improvement in TG (-17.1 [-43.0; -8.8]), TC (-18.6 [-35.9; -1.3]), LDL-c (-10.3 [-26.8; -6.2])”

    Human trialin older women with depressive disorders12 weeksfemalesn = 27

    Twelve Weeks of Resistance Training is Equally as Effective at Improving Cardiovascular Risk Factors in Older Women With and Without History of Depression: A Cross-Over Trial

    Journal of geriatric psychiatry and neurology

  3. Resistance training decreases triglyceride in humans (compared with the control group).

    “the exercise group showed significant post-intervention improvements in fasting blood glucose (F(1,49) = 3.982, p = 0.052), TG (F(1,49) = 8.670, p = 0.011), insulin level (F(1,49) = 10.484, p = 0.002), and HOMA-IR (F(1,49) = 7.547, p = 0.009”

    Human trialcompared with the control groupsix-monthn = 51

    A Non-Randomized Combined Program of Walking and Low-Load Resistance Exercise Improves Cognitive Function and Cardiometabolic Risk Factors in Community-Dwelling Elderly Women

    Healthcare (Basel, Switzerland)

  4. Resistance training decreases triglyceride in breast cancer survivors undergoing tamoxifen (156 ± 45 to 123 ± 43 mg/dL).

    “Triglycerides (156 ± 45 to 123 ± 43 mg/dL) and total cholesterol (202 ± 13 to 186 ± 16 mg/dL) decreased after the RT”

    Human trialin breast cancer survivors undergoing tamoxifen12 weeksfemalesn = 14

    Exercise training and detraining effects on body composition, muscle strength and lipid, inflammatory and oxidative markers in breast cancer survivors under tamoxifen treatment

    Life sciences

  5. Resistance training showed no clear effect on triglyceride in humans (versus control group).

    “significant improvements over time for all but one (triglycerides) biomarkers for EBT comparing to CON were obtained”

    Human trialversus control groupchair-based, low-load, elastic band12 weeksfemalesn = 168

    Effects of Chair-Based, Low-Load Elastic Band Resistance Training on Functional Fitness and Metabolic Biomarkers in Older Women

    Journal of sports science & medicine

  6. Resistance training decreases triglyceride in humans after a high-fat meal, independent of age (32.1 ± 27.1 mg/dL and 52.7 ± 26.8 mg/dL lower at 3 and 5 hours; TG AUC 15% to 31% lower).

    “TGs were 32.1 ± 27.1 mg/dL and 52.7 ± 26.8 mg/dL lower in RE than CON at 3 and 5 hours, respectively”

    Human trialafter a high-fat meal, independent of age5 hours post-mealmales

    Resistance exercise attenuates postprandial metabolic responses to a high-fat meal similarly in younger and older men

    Nutrition research (New York, N.Y.)

  7. Resistance training showed no clear effect on triglyceride in humans (MD -0.10 mmol/L, 95% CrI -0.25 to 0.05).

    “RT did not reach statistical significance (MD: -0.10 mmol/L, 95% CrI: -0.25 to 0.05).”

    Reviewresistance trainingfemalesn = 2,046

    Exercise dose and triglyceride reduction in postmenopausal women: a systematic review and model-based network meta-analysis

    Frontiers in physiology

  8. Resistance training decreases triglyceride in humans (adults with overweight or obesity) (MD = -0.17 mmol/L; 95% CI: -0.30 to -0.04).

    “RT significantly reduced diastolic blood pressure (MD = -1.53 mmHg; 95% CI: -2.16 to -0.91; p < 0.01), LDL-C (MD = -0.25 mmol/L; 95% CI: -0.41 to -0.08; p < 0.01), and triglycerides (MD = -0.17 mmol/L; 95% CI: -0.30 to -0.04; p = 0.01).”

    Reviewadults with overweight or obesity2-3 sessions/week≥ 7 weeksn = 454

    Effects of Moderate-Frequency Resistance Training on Cardiometabolic Risk Factors in Adults With Overweight or Obesity: A Systematic Review and Meta-Analysis

    Obesity reviews : an official journal of the International Association for the Study of Obesity

More on Resistance training

Intermittent fasting

downin humans5no changein humans1downin mice1downin rats1−24%

8 studies
  1. Intermittent fasting decreases triglyceride in the 5:2 IF group.

    “The 5:2 IF group also experienced a significant decrease in serum triglyceride levels (P = 0.04).”

    Human trialin the 5:2 IF groupthree monthsn = 40

    Comparative effects of intermittent fasting and calorie restriction on cardiovascular health in adults with overweight or obesity

    Scientific reports

  2. Intermittent fasting decreases triglyceride in humans (obesity with type 2 diabetes) (-1.139 mmol/L [SD 1.335 mmol/L]).

    “triglycerides (-1.139 mmol/L [SD 1.335 mmol/L])”

    Human trialobesity with type 2 diabetes16 weeksn = 63

    OR19-08 Intermittent versus Time-Restricted or Continuous Calorie Restriction for the Management of Obesity with Type 2 Diabetes: A Randomized Clinical Trial

    ENDO 2025 abstract

  3. Intermittent fasting showed no clear effect on triglyceride in humans.

    “However, IF did not affect triglyceride levels or physical performance.”

    Human trialfive monthsmales

    The influence of intermittent fasting on body metrics, lipid profile, and physical performance in young and middle-aged men

    Nutrition and health

  4. Intermittent fasting decreases triglyceride in type 2 diabetes mellitus (MD -15.16, 95% CI -25.97 to -4.34).

    “triglycerides (MD, -15.16; 95% CI, -25.97 to -4.34; p=0.01)”

    Reviewin type 2 diabetes mellitus

    Effects of Ramadan fasting on glycemic control and lipid profile in type 2 diabetes mellitus: a systematic review and meta-analysis of clinical studies

    Journal of Yeungnam medical science

  5. Intermittent fasting decreases triglyceride in humans (umbrella review of meta-analyses).

    “IF appears to present modest benefits on lipid profile, mainly in TG reduction, while data on LDL-C, HDL-C, and TC remains inconsistent.”

    Reviewumbrella review of meta-analyses

    The impact of intermittent fasting on lipid profile - an umbrella review

    Nutrition, metabolism, and cardiovascular diseases : NMCD

  6. Intermittent fasting decreases triglyceride in humans (overweight and obese without metabolic disease) (MD = -0.32 mmol/L, 95% CI (-0.50, -0.15), p < 0.001).

    “TG (MD = -0.32 mmol/L, 95% CI (-0.50, -0.15, p < 0.001) were significantly lower”

    Reviewoverweight and obese without metabolic disease2-6 weeks

    Effectiveness of an intermittent fasting diet versus regular diet on fat loss in overweight and obese middle-aged and elderly people without metabolic disease: a systematic review and meta-analysis of randomized controlled trials

    The journal of nutrition, health & aging

  7. Intermittent fasting decreases triglyceride in rats (diet-induced obese rats) (-23.94%).

    “and triacylglycerols (on average 23.94%) versus the obese group”

    Animalsdiet-induced obese rats4 wk

    Intermittent fasting associated with coconut oil (Cocos nucifera L.) alters gut-liver axis parameters in diet-induced obese rats

    Nutrition (Burbank, Los Angeles County, Calif.)

  8. Intermittent fasting decreases triglyceride in db/db mice with type 2 diabetes mellitus.

    “reductions of hepatic and plasma triglycerides”

    Animalsin db/db mice with type 2 diabetes mellitus12 weeksmales

    The daily caloric restriction and alternate-day fasting ameliorated lipid dysregulation in type 2 diabetic mice by downregulating hepatic pescadillo 1

    European journal of nutrition

More on Intermittent fasting

Omega-3 fatty acids

downin humans8

8 studies
  1. Omega-3 fatty acids decrease triglyceride in humans.

    “n-3 PUFAs reduced total triglycerides, maintained HDL, reduced systolic blood pressure”

    Human trialethyl esters3.9 g/d6 mo

    A Randomized Trial of ω-3 Fatty Acid Supplementation and Circulating Lipoprotein Subclasses in Healthy Older Adults

    The Journal of nutrition

  2. Omega-3 fatty acids decrease triglyceride in humans (HIV infection) (WMD -0.86 mg/dL, 95% CI -1.18 to -0.54).

    “a clear reduction in triglycerides (WMD - 0.86 mg/dL, 95% CI -1.18 to -0.54)”

    ReviewHIV infectionn = 1,118

    Effect of omega-3 supplementation on metabolic and inflammatory markers in adults with HIV infection: a systematic review and meta-analysis

    Frontiers in nutrition

  3. Omega-3 fatty acids decrease triglyceride in overweight or obesity.

    “LC n3-PUFA significantly reduced triglyceride levels.”

    Reviewin overweight or obesity

    Nutraceuticals for the management of weight and inflammation-related complications in obesity: a pediatric perspective. Systematic review and network meta-analysis

    Frontiers in nutrition

  4. Omega-3 fatty acids decrease triglyceride in RA patients (SMD: -0.47; 95% CI: -0.78, -0.16).

    “omega-3 supplementation decreased triglyceride (TG) in RA patients (SMD: -0.47; 95% CI: -0.78, -0.16; P = 0.003)”

    Reviewin RA patients

    Effects of omega-3 supplementation on lipid metabolism, inflammation, and disease activity in rheumatoid arthritis: a meta-analysis of randomized controlled trials

    Clinical rheumatology

  5. Omega-3 fatty acids decrease triglyceride in humans (gestational diabetes mellitus) (WMD = -0.18 mmol/L; 95 % CI: -0.29, -0.08).

    “triglycerides (WMD = -0.18 mmol/L; 95 % CI: -0.29, -0.08) and very low-density lipoprotein cholesterol (WMD = -0.1 mmol/L; 95 % CI: -0.16, -0.03) decreased in the omega-3 group”

    Reviewgestational diabetes mellitusn = 331

    Effects of omega-3 supplementation on glucose and lipid metabolism in patients with gestational diabetes: A meta-analysis of randomized controlled trials

    Journal of diabetes and its complications

  6. Omega-3 fatty acids decrease triglyceride in humans (postmenopausal women) (WMD, -17.8 mg/dL; 95% CI, -26 to -9.6; P < 0.001).

    “Omega-3 fatty acid supplementation resulted in a decrease in triglyceride concentrations (weighted mean difference [WMD], -17.8 mg/dL; 95% CI, -26 to -9.6; P < 0.001)”

    Reviewpostmenopausal women

    Does Omega-3 Fatty Acid Supplementation Have Favorable Effects on the Lipid Profile in Postmenopausal Women? A Systematic Review and Dose-response Meta-analysis of Randomized Controlled Trials

    Clinical therapeutics

  7. Omega-3 fatty acids decrease triglyceride in humans (hypertriglyceridemia).

    “the use of omega-3 supplements consumption is the dietary component with the highest number of randomized clinical trials (RCT) carried out with effective results on reducing TG.”

    Reviewhypertriglyceridemia

    The Effect of Dietary Interventions on Hypertriglyceridemia: From Public Health to Molecular Nutrition Evidence

    Nutrients

  8. Omega-3 fatty acids decrease triglyceride in women with PCOS.

    “lipid profile modulation (i.e. decrease in total cholesterol, triglycerides, and elevation of high-density lipoprotein)”

    Reviewin women with PCOS

    Omega-3 supplementation in the treatment of polycystic ovary syndrome (PCOS) - a review of clinical trials and cohort

    Endocrine regulations

More on Omega-3 fatty acids

Combined aerobic and resistance training

downin humans7

7 studies
  1. Combined aerobic and resistance training decreases triglyceride in humans (MD -0.255, 95% CI -0.355 to -0.156).

    “In the modality network, CE had the largest average estimate (MD −0.255, 95% CI −0.355 to −0.156), followed by HIIT (−0.225, −0.392 to −0.059) and AE (−0.130, −0.185 to −0.074); RT was inconclusive (−0.057, −0.153 to 0.039).”

    Human trial

    Dose-Response Relationships Between Exercise Modalities and Triglyceride Reduction in Adults: A Systematic Review and Model-Based Network Meta-Analysis

    Metabolites

  2. Combined aerobic and resistance training decreases triglyceride in humans (MD -0.255 mmol/L).

    “CE had the largest average network estimate (MD -0.255 mmol/L)”

    Human trial

    Dose-Response Relationships Between Exercise Modalities and Triglyceride Reduction in Adults: A Systematic Review and Model-Based Network Meta-Analysis

    Metabolites

  3. Combined aerobic and resistance training decreases triglyceride in humans (larger TG decrease than with resistance training).

    “For TG, the overall decrease was attenuated in RT relative to CT.”

    Human triallarger TG decrease than with resistance training12 weeksfemales

    Effects of 12 weeks of resistance and concurrent training with graded protein intakes on lipid profile, kidney and liver biomarkers in middle-aged to older women

    Research SquarePreprint

  4. Combined aerobic and resistance training decreases triglyceride in humans.

    “Triglycerides and blood urea nitrogen decreased, whereas total bilirubin increased (p < .05).”

    Human trialblood8 weeksfemalesn = 36

    Effects of Combined Exercise on Physical Fitness and Blood Biochemical Markers Related to Liver Function, Lipid Metabolism, and Renal Function in Adult Women: A Comparison According to Menopausal Status

    Journal of Sport and Dance Science

  5. Combined aerobic and resistance training decreases triglyceride in humans (overweight group only).

    “Blood triglycerides were reduced only in the overweight group.”

    Human trialoverweight group only14 weeksfemales

    Impact of combined exercise on blood DNA methylation and physical health in older women with obesity

    PloS one

  6. Combined aerobic and resistance training decreases triglyceride in humans (MD -0.17 mmol/L, 95% CrI -0.31 to -0.03).

    “CE (MD: -0.17 mmol/L, 95% CrI: -0.31 to -0.03) significantly reduced TG relative to CON”

    Reviewcombined exercisefemalesn = 2,046

    Exercise dose and triglyceride reduction in postmenopausal women: a systematic review and model-based network meta-analysis

    Frontiers in physiology

  7. Combined aerobic and resistance training decreases triglyceride in humans (stable coronary artery disease) (MD=-0.49, 95% CrI -0.74 to -0.23).

    “triglycerides (TG) (MD=-0.49, 95% CrI -0.74 to -0.23), and outperformed continuous aerobic exercise (CAE) in both outcomes”

    Reviewstable coronary artery disease

    Effects of different exercise interventions on lipid profiles in patients with stable coronary artery disease: a systematic review and network meta-analysis

    European journal of physical and rehabilitation medicine

  8. Combined aerobic and resistance training decreases triglyceride in humans (postmenopausal women) (Highest TG ranking: SUCRA = 96.2).

    “CT had the best effect on improving TG, HDL-C, and DBP.”

    Reviewpostmenopausal womenfemales

    Effect of Exercise on Vascular Function and Blood Lipids in Postmenopausal Women: A Systematic Review and Network Meta-Analysis

    International journal of environmental research and public health

More on Combined aerobic and resistance training

Vitamin D

downin humans6

6 studies
  1. Vitamin D decreases triglyceride in humans (Metabolic syndrome; benefit reported in a subset of trials).

    “Significant improvements were reported in triglycerides and insulin resistance indices in a subset of trials”

    ReviewMetabolic syndrome; benefit reported in a subset of trials

    Effect of vitamin D supplementation on metabolic syndrome parameters in adults: a systematic review of randomized controlled trials exploring the role of baseline vitamin D status and supplementation dose

    Frontiers in nutrition

  2. Vitamin D decreases triglyceride in humans (overweight or obesity) (WMD: -6.13 mg/dL; 95% CI: -8.99 to -3.28).

    “Vitamin D supplementation resulted in significant reductions in TG (WMD: -6.13 mg/dL; 95% CI: -8.99 to -3.28; P = .000)”

    Reviewoverweight or obesityfemales

    Effect of Vitamin D Supplementation on Lipid Profile in Overweight or Obese Women: A Meta-analysis and Systematic Review of Randomized Controlled Trials

    Nutrition reviews

  3. Vitamin D decreases triglyceride in humans (Weighted mean difference: -4.63 mg/dL (95% CI -7.70 to -1.57); standardized mean difference: -0.15 (95% CI -0.23 to -0.08)).

    “In the weighted mean difference analysis, vitamin D significantly decreased only TG levels”

    Review

    The Effect of Vitamin D Supplementation on Lipid Profiles: an Umbrella Review of Meta-Analyses

    Advances in nutrition (Bethesda, Md.)

  4. Vitamin D decreases triglyceride in humans (SMD: - 0.45 mg/dl; 95% CI: - 0.86, - 0.04).

    “and triglyceride (TG) (SMD: - 0.45 mg/dl; 95% CI: - 0.86, - 0.04) with VDS compared to the placebo.”

    Review

    Effect of vitamin D supplementation on cardiac-metabolic risk factors in elderly: a systematic review and meta-analysis of clinical trials

    Diabetology & metabolic syndrome

  5. Vitamin D decreases triglyceride in postmenopausal females versus controls (WMD: -3.55 mg/dL, 95% CI: -5.34 to -1.76, P < 0.001).

    “Supplementation with vitamin D decreased TG (WMD: -3.55 mg/dL, 95% CI: -5.34 to -1.76, P < 0.001) in postmenopausal females versus controls.”

    Reviewin postmenopausal females versus controls

    The effect of vitamin D on the lipid profile as a risk factor for coronary heart disease in postmenopausal women: a meta-analysis and systematic review of randomized controlled trials

    Experimental gerontology

  6. Vitamin D decreases triglyceride in humans (polycystic ovary syndrome) (-11.88 mg/dL (95% CI: -17.03 to -6.73)).

    “VitD supplementation reduced serum triglyceride levels (-11.88 mg/dL; 95% confidence interval [CI]: -17.03 to -6.73)”

    Reviewpolycystic ovary syndromen = 467

    Influence of vitamin D supplementation on lipid levels in polycystic ovary syndrome patients: a meta-analysis of randomized controlled trials

    The Journal of international medical research

More on Vitamin D

Curcumin

downin humans5no changein humans1

6 studies
  1. Curcumin decreases triglyceride in humans (Brazilian women with high waist circumference) (p < 0.001 for TGs, p = 0.001 for TC).

    “TGs (p < 0.001) and TC (p = 0.001) compared with the PG”

    Human trialBrazilian women with high waist circumferencecapsule (Curcumin C3 Complex®)500 mg/day90 daysfemalesn = 35

    Curcumin supplementation reduces blood glucose and serum lipids of Brazilian women with high waist circumference: a randomized clinical trial

    Archives of endocrinology and metabolism

  2. Curcumin decreases triglyceride in humans (versus placebo at end of study) (p < .05 versus placebo).

    “Curcumin supplementation significantly decreased homeostatic model assessment for insulin resistance (HOMA-IR), erythrocyte sedimentation rate, serum levels of high-sensitivity C-reactive protein and triglycerides”

    Human trialversus placebo at end of study500 mg once a day8 weeksfemalesn = 48

    Effects of curcumin supplementation on metabolic parameters, inflammatory factors and obesity values in women with rheumatoid arthritis: A randomized, double-blind, placebo-controlled clinical trial

    Phytotherapy research : PTR

  3. Curcumin decreases triglyceride in humans (nano-micelle curcumin versus placebo) (change -60.5 ± 121.7 vs 13.1 ± 78.1 mg/dL between groups).

    “a significant reduction in the average change of triglyceride (TG) levels (-60.5 ± 121.7 vs. 13.1 ± 78.1 mg/dL; p < .05)”

    Human trialnano-micelle curcumin versus placebonano-micelle80 mg/day12 weeksn = 50

    The effects of nano-curcumin supplementation on glycemic control, blood pressure, lipid profile, and insulin resistance in patients with the metabolic syndrome: A randomized, double-blind clinical trial

    Phytotherapy research : PTR

  4. Curcumin decreases triglyceride in adults with prediabetes or type 2 diabetes (WMD: -13.73 mg/dL; 95% CI: -19.49, -7.96).

    “Curcumin/turmeric supplementation significantly reduced triglycerides (WMD: -13.73 mg/dL; 95% CI: -19.49, -7.96)”

    Reviewin adults with prediabetes or type 2 diabetes

    Effects of Curcumin/Turmeric Supplementation on Lipid Profile in Subjects With Prediabetes and Diabetes: A Systematic Review and Meta-Analysis

    Lipids

  5. Curcumin decreases triglyceride in humans (updated meta-analysis of RCTs) (MD -13.15 mg/dL (95% CI: -17.31, -8.98)).

    “and TG, with mean differences (MDs) of -7.76 mg/dL (95% CI: -11.29, -4.22; I2 = 97%), -5.84 mg/dL (95% CI: -11.63, -0.05; I2 = 98%), and -13.15 mg/dL (95% CI: -17.31, -8.98”

    Reviewupdated meta-analysis of RCTs

    An Umbrella Review of Systematic Reviews and Meta-analyses of Randomized Controlled Trials Investigating the Effect of Curcumin Supplementation on Lipid Profiles

    Nutrition reviews

  6. Curcumin showed no clear effect on triglyceride in humans (versus placebo) (-0.05 (95% CI: -0.20-0.11, p = .56)).

    “TG level in the curcumin group were 0.05 lower versus the placebo (95% CI: -0.20-0.11; Z = 0.58; p = .56).”

    Reviewversus placebo

    Curcumin and blood lipid levels: an updated systematic review and meta-analysis of randomised clinical trials

    Archives of physiology and biochemistry

More on Curcumin

Aerobic exercise

downin humans4

4 studies
  1. Aerobic exercise decreases triglyceride in humans (-0.130, -0.185 to -0.074).

    “In the modality network, CE had the largest average estimate (MD −0.255, 95% CI −0.355 to −0.156), followed by HIIT (−0.225, −0.392 to −0.059) and AE (−0.130, −0.185 to −0.074); RT was inconclusive (−0.057, −0.153 to 0.039).”

    Human trial

    Dose-Response Relationships Between Exercise Modalities and Triglyceride Reduction in Adults: A Systematic Review and Model-Based Network Meta-Analysis

    Metabolites

  2. Aerobic exercise decreases triglyceride in humans (MD -0.130 mmol/L).

    “followed by HIIT (-0.225) and AE (-0.130)”

    Human trial

    Dose-Response Relationships Between Exercise Modalities and Triglyceride Reduction in Adults: A Systematic Review and Model-Based Network Meta-Analysis

    Metabolites

  3. Aerobic exercise decreases triglyceride in humans (metabolic syndrome).

    “aerobic training was more effective at decreasing blood pressure and triglycerides”

    Human trialmetabolic syndromethree times per week, 60–75% HRmax12 weeksfemalesn = 500

    Effects of Aerobic vs. Resistance Training on Metabolic Syndrome in Postmenopausal Women Using Wearable Technology

    International journal of human movement and sports sciences

  4. Aerobic exercise decreases triglyceride in humans (MD -0.20 mmol/L, 95% CrI -0.27 to -0.13).

    “AE (MD: -0.20 mmol/L, 95% CrI: -0.27 to -0.13), and CE (MD: -0.17 mmol/L, 95% CrI: -0.31 to -0.03) significantly reduced TG relative to CON”

    Reviewaerobic exercisefemalesn = 2,046

    Exercise dose and triglyceride reduction in postmenopausal women: a systematic review and model-based network meta-analysis

    Frontiers in physiology

  5. Aerobic exercise decreases triglyceride in humans (non-aging overweight or obese adults).

    “aerobic exercise may be optimal for reducing TG”

    Reviewnon-aging overweight or obese adults

    Effects of Exercise Combined With Green Tea in Non-Aging on Anthropometric and Blood Lipids in Non-Aging Overweight/Obesity Adults-A Systematic Review and Network Meta-Analysis

    medRxivPreprint

More on Aerobic exercise

Olezarsen

downin humans4

4 studies
  1. Olezarsen decreases triglyceride in humans (MD −50.52 [−55.92, −45.12]).

    “Olezarsen reduced triglyceride levels with both doses (50 mg: MD −50.52 [−55.92, −45.12]; 80 mg: MD −54.55 [−59.54, −49.56]).”

    Human trial50 mg12 months

    Dose-related effects of olezarsen in hypertriglyceridaemia: a systematic review and meta-analysis of 2,610 patients

    ESC Congress 2026 abstract

  2. Olezarsen decreases triglyceride in humans (severe hypertriglyceridemia) (68-79% reductions).

    “Median achieved fasting TGs at week 53 of OLE were 142, 129, and 129 mg/dL for the 3 groups, respectively, representing 68-79% reductions from baseline”

    Human trialsevere hypertriglyceridemia80 mg Q4Wweek 53 of OLEn = 884

    Long-term efficacy and safety of olezarsen in patients with severe hypertriglyceridemia

    ESC Congress 2026 abstract

  3. Olezarsen decreases triglyceride in humans (reduced by 63.9% over placebo).

    “At 6 months, olezarsen reduced triglycerides by 63.9%, remnant cholesterol by 71.9%, and apoB by 16.0% over placebo”

    Human trialpatients with largely moderate hypertriglyceridemia on standard-of-care lipid-lowering therapy6 months

    Effect of APOC3 Inhibition With Olezarsen on Coronary Atherosclerosis: Essence-TIMI 73b Imaging Study

    Circulation

  4. Olezarsen decreases triglyceride in humans (versus placebo in randomized trials) (MD -59.20 mg/dL).

    “Olezarsen significantly reduced triglycerides (mean difference [MD] -59.20 mg/dL)”

    Reviewversus placebo in randomized trials

    Efficacy and Safety of Olezarsen for the Management of Dyslipidemia: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials

    The American journal of cardiology

More on Olezarsen

Acarbose

downin humans4

4 studies
  1. Acarbose decreases triglyceride in humans (WMD -13.43 mg/dl (95% CI -19.20 to -7.67)).

    “acarbose resulted in a reduction in levels of TG (WMD = - 13.43 mg/dl, 95% CI: - 19.20, - 7.67; P < 0.001)”

    Human trialn = 7,046

    The effect of acarbose on lipid profiles in adults: a systematic review and meta-analysis of randomized clinical trials

    BMC pharmacology & toxicology

  2. Acarbose decreases triglyceride in humans (overweight or obese patients without diabetes; placebo-controlled) (WMD -0.21 (95% CI -0.33, -0.09) mmol/l, P = 0.0006).

    “An important finding of our research is that TG was the only significantly reduced parameter in the acarbose group.”

    Human trialoverweight or obese patients without diabetes; placebo-controlled

    The Effects of Acarbose on Non-Diabetic Overweight and Obese Patients: A Meta-Analysis

    Advances in therapy

  3. Acarbose decreases triglyceride in humans (added to metformin and insulin glargine) (lowest among groups, p = 0.005).

    “Triglycerides were lowest in acarbose group (p = 0.005).”

    Human trialadded to metformin and insulin glargine4 months

    A time to revisit the two oldest prandial anti-diabetes agents: acarbose and repaglinide

    Endocrine

  4. Acarbose decreases triglyceride in humans (versus placebo in impaired glucose tolerance and diabetic patients) (WMD -13.89 mg/dL).

    “triglyceride (TG) (WMD = -13.89 mg/dL; 95%CI: -20.69, -7.09; p < 0.001)”

    Reviewversus placebo in impaired glucose tolerance and diabetic patients

    The effects of acarbose treatment on cardiovascular risk factors in impaired glucose tolerance and diabetic patients: a systematic review and dose-response meta-analysis of randomized clinical trials

    Frontiers in nutrition

More on Acarbose

Time-restricted feeding

downin humans2downin flies1

3 studies
  1. Time-restricted feeding decreases triglyceride in humans.

    “TRF was linked with significant reductions in triglycerides (P = 0.003)”

    Human trial12 weeks

    Ten-Hour Time-Restricted Feeding Improves Post-Kidney Transplantation Dyslipidemia:a randomized controlled trial

    Research SquarePreprint

  2. Time-restricted feeding decreases triglyceride in humans (particularly in overweight individuals).

    “The evidence suggests that TRE may modestly reduce TG levels, particularly in overweight individuals, with a limited impact on LDL-C, HDL-C, and TC.”

    Reviewparticularly in overweight individuals

    The impact of intermittent fasting on lipid profile - an umbrella review

    Nutrition, metabolism, and cardiovascular diseases : NMCD

  3. Time-restricted feeding decreases triglyceride in high-fat diet-fed flies switched to control diet.

    “Flies with metabolic damage that received TRF showed lower total triglyceride content, Nlaz expression, circulating glucose, and weight compared to Ad libitum.”

    Model organismsin high-fat diet-fed flies switched to control dietseven days

    "Effect of time-restricted feeding on high-fat diet-induced metabolic dysfunction in Drosophila melanogaster"

    Biochimica et biophysica acta. Molecular basis of disease

More on Time-restricted feeding

All 236

Effects

28

Cognitive function

no changein humans1upin humans1downin humans1

3 studies
  1. Triglyceride was not clearly linked with cognitive function in patients receiving maintenance hemodialysis.

    “serum LDL-C and TG levels showed no significant associations with either cognitive assessment”

    Humansin patients receiving maintenance hemodialysisserumn = 265

    High-density lipoprotein cholesterol and cognitive function in patients undergoing hemodialysis

    Clinical and experimental nephrology

  2. Triglyceride is linked with better cognitive function in APOE ε4 carriers (0.001 (SD 0.001, p=0.045)).

    “higher TG levels were significantly associated with decelerated CD, 0.001 (0.001,0.045)”

    Humansin APOE ε4 carriersn = 3,496

    Longitudinal associations between lipid panel and cognitive decline modified by APOE 4 carrier status in biracial community-dwelling older adults: Findings from the Chicago health and aging project

    Archives of gerontology and geriatrics

  3. Triglyceride is linked with worse cognitive function in humans among prediabetes patients.

    “among prediabetes patients, triglyceride concentrations were negatively associated with cognitive function”

    Humansamong prediabetes patients

    Longitudinal Associations of Newly Diagnosed Prediabetes and Diabetes with Cognitive Function among Chinese Adults Aged 45 Years and Older

    Journal of diabetes research

Coronary artery disease

mediatesin humans1no changein humans1

2 studies
  1. Triglyceride is linked with coronary artery disease in adiposity with metabolic dysfunction.

    “The unhealthy obese phenotype acted through triglycerides and diabetes”

    Humansin adiposity with metabolic dysfunctionn = 60,801

    Divergent genetic mediator signatures of adiposity-related metabolic liabilities and coronary artery disease

    medRxivPreprint

  2. Triglyceride was not clearly linked with coronary artery disease in humans (HDL-C ≥ 1.8 mmol/L).

    “For participants with HDL-C ≥ 1.8 mmol/L, no increase was observed in CAD risk associated with TG levels in either men or women.”

    HumansHDL-C ≥ 1.8 mmol/Lmean follow-up of 5.55 ± 2.39 years

    The Relationship Between Triglycerides and Coronary Artery Disease Stratified by Sex and High-Density Lipoprotein Cholesterol in Men and Women

    Diabetes/metabolism research and reviews

More on Coronary artery disease

Uric acid

no changein humans1mediatesin humans1

1 study
  1. Triglyceride was not clearly linked with uric acid in humans (Mediation analysis of the association between age and uric acid) (Indirect effect = 0.101, 95% CI −0.007–0.210; p > 0.05).

    “no such mediating effect was observed in males (indirect effect = 0.101, 95% CI: −0.007 to 0.210, p > 0.05).”

    HumansMediation analysis of the association between age and uric acidmales

    A cross-sectional study of routine hematological and biochemical parameters with age- and sex-specific analyses in mid-to-high-altitude regions of southwestern China

    Frontiers in public health

  2. Triglyceride is linked with uric acid in humans (Mediation of the association between age and uric acid) (Indirect effect = 4.435, 95% CI 4.214–4.679; p < 0.001).

    “TG exerted a complete mediating role in the association pathway between age and UA, which was statistically significant exclusively in females”

    HumansMediation of the association between age and uric acidfemales

    A cross-sectional study of routine hematological and biochemical parameters with age- and sex-specific analyses in mid-to-high-altitude regions of southwestern China

    Frontiers in public health

More on Uric acid

Incident heart failure

no changein humans1

1 study
  1. Triglyceride was not clearly linked with incident heart failure in humans (Models adjusted for age, sex, and BMI).

    “neither marker was associated with HF, all-cause death, or cardiovascular death”

    HumansModels adjusted for age, sex, and BMIheartn = 2,036

    Combined blood marker not linked to worsening heart relaxation

    AHA Scientific Sessions 2026 abstract

More on Incident heart failure

Diastolic dysfunction progression

no changein humans1

1 study
  1. Triglyceride was not clearly linked with diastolic dysfunction progression in humans Across triglyceride tertiles (p=0.55).

    “DD progression did not differ across TyG tertiles (6.5%, 8.2%, 8.5%; p=0.52) or triglyceride tertiles (p=0.55)”

    HumansAcross triglyceride tertilesheartn = 1,205

    Combined blood marker not linked to worsening heart relaxation

    AHA Scientific Sessions 2026 abstract

More on Diastolic dysfunction progression

Mortality

no changein humans1HR 1.057

1 study
  1. Triglyceride was not clearly linked with mortality in humans (Coronary heart disease; high TG-PRS; TG≥1.67 mmol/L) (HR=1.057 per 1 mmol/L TG increment; P=0.5147).

    “but not in high-TG subgroups (TG≥1.67 mmol/L; HR=1.057, P=0.5147).”

    HumansCoronary heart disease; high TG-PRS; TG≥1.67 mmol/L10-year follow-up

    Genetic modifiers of triglyceride-mediated mortality in coronary heart disease: a large cohort study of polygenic risk and circulating triglyceride level interaction

    ESC Congress 2026 abstract

Threshold discordance

upin humans1

1 study
  1. Triglyceride is linked with higher threshold discordance in humans across triglyceride strata.

    “Discordance increased with triglycerides.”

    Humansacross triglyceride stratan = 397,490

    Formula-dependent LDL-C threshold classification and reporting uncertainty in the UK Biobank

    Clinical chemistry and laboratory medicine

More on Threshold discordance

Cardiovascular disease

mediatesin humans1

1 study
  1. Triglyceride is linked with cardiovascular disease in humans (exposure to PrP) (9.7%).

    “while the triglyceride-related mediation proportion was 9.7% for the PrP-CVD association”

    Humansexposure to PrPn = 3,831

    Cardiovascular risks of plastic-associated chemicals: Integrating mixture modeling and SHAP-explained machine learning to unravel linear and non-linear associations

    Environmental research

More on Cardiovascular disease

Insulin resistance

mediatesin humans1

1 study
  1. Triglyceride is linked with insulin resistance in humans (Indirect coefficients: WHR 0.55 (95% CI 0.11–2.63); BMI 0.76 (0.17–2.27); WC 0.72 (0.04–2.63)).

    “TG significantly mediated the associations between WHR and IR”

    HumansStatistical mediation of associations of waist-to-hip ratio, BMI, and waist circumference with insulin resistancen = 169

    Mediating Effects of Lipid Biomarkers and Sex-Specific Moderation on the Associations Between Anthropometric and Dietary Factors With Insulin Resistance

    Journal of obesity

More on Insulin resistance

Dilated cardiomyopathy

mediatesin humans1

1 study
  1. Triglyceride is linked with dilated cardiomyopathy in humans (mediation of the effect of depression) (100% mediation proportion).

    “In the causal pathway between depression and DCM, triglycerides were found to mediate 100% of the effect.”

    Humansmediation of the effect of depression

    Triglycerides play a crucial role in the pathway from depression to cardiomyopathy: A mediation Mendelian randomization study

    Medicine

More on Dilated cardiomyopathy

All 28

Upstream

35

Depression

upin humans2OR 1.093–2.46

2 studies
  1. Depression is linked with higher triglyceride in humans (severe depression) (adjusted OR = 2.460, 95% CI: 1.304-4.661, p = 0.005).

    “increased triglycerides (adjusted OR = 2.460, 95% CI: 1.304-4.661, p = 0.005)”

    Humanssevere depressionn = 585

    Associations Between Depression Severity, Antidepressant Use, and Metabolic Syndrome Components Among Chinese Adults: A Cross-Sectional Study Based on Historical Medical Records

    Actas espanolas de psiquiatria

  2. Depression is linked with higher triglyceride in humans (OR 1.093, 95% CI 1.041–1.149).

    “Exacerbation of depression was observed to lead to an elevation in triglyceride levels”

    Humans

    Triglycerides play a crucial role in the pathway from depression to cardiomyopathy: A mediation Mendelian randomization study

    Medicine

More on Depression

APOC3

upin reviews1

1 study
  1. APOC3 increases triglyceride (Pharmacologic inhibition with RNA-based agents).

    “Pharmacologic inhibition of apoC-III with RNA-based agents has led to substantial reductions in apoC-III and triglycerides”

    ReviewPharmacologic inhibition with RNA-based agents

    Targeting Apolipoprotein C-III in Hypertriglyceridemia: Implications for Pancreatitis and Cardiovascular risk

    Current atherosclerosis reports

More on APOC3

ABCG1 methylation

mediatesin humans1

1 study
  1. ABCG1 methylation is linked with triglyceride in humans (63% of the DunedinPACE–TG association).

    “ABCG1 methylation accounted for 63% of the DunedinPACE–TG association, an estimate that was essentially unchanged when the causal ordering was reversed.”

    HumansMediation analysis of the DunedinPACE–TG association; reversing causal ordering yielded an essentially unchanged estimateblood

    Blood fat links to DNA marks replicated in Korean adults

    Clinical epigenetics

More on ABCG1 methylation

Physical inactivity and depressive symptoms

upin humans1OR 2.16

1 study
  1. physical inactivity and depressive symptoms are linked with higher triglyceride in humans (compared to active without depressive symptoms) (OR: 2.16; 95%CI: 2.01-2.32).

    “elevated triglycerides (OR: 2.16; 95%CI: 2.01-2.32)”

    Humanscompared to active without depressive symptomsn = 51,592

    Association between physical activity, depressive symptoms, and cardiometabolic risk factors in brazilian adults

    Current problems in cardiology

Sarcopenic obesity

downin humans1

1 study
  1. Sarcopenic obesity is linked with lower triglyceride in humans (compared with patients with simple obesity).

    “SO patients had lower TG levels than patients with simple obesity”

    Humanscompared with patients with simple obesity

    Systematic review and meta-analysis of biomarkers of sarcopenia and sarcopenic obesity

    Medicine

More on Sarcopenic obesity

Sarcopenic obesity

upin humans1

1 study
  1. Sarcopenic obesity is linked with higher triglyceride in humans (sarcopenic obesity in frail older adults with diabetes).

    “Sarcopenic obesity showed an insulin resistance-related cluster comprising greater central adiposity, higher triglycerides and TyG index, metabolic syndrome in all participants, and greater insulin requirements.”

    Humanssarcopenic obesity in frail older adults with diabetes

    Body composition-defined sarcopenia phenotypes, diabetes complications, and CGM-derived glycemic profiles in frail older adults with diabetes: a cross-sectional study

    The journal of nutrition, health & aging

CCHa1

upin flies1

1 study
  1. CCHa1 increases triglyceride in ccha1 mutant flies.

    “Both ccha1 mutant males and females fared better under starvation stress and had higher triglyceride reserves.”

    Model organismsin ccha1 mutant flies

    The curious case of CCHamide1: a role for CCHamide1 in sleep, metabolism, and fitness in Drosophila melanogaster

    Genetics

More on CCHa1

Mitochondrial DNA copy number

mediatesin humans1

1 study
  1. Mitochondrial DNA copy number is linked with triglyceride in humans (mediation of PPD-Q-induced serum triglyceride elevation) (34% (95% CI: 9.3 -138%) to 70% (95% CI: 12 -266%) of the total TG-elevating effect).

    “mtDNAcn mediated 34 (95% CI: 9.3 -138%)-70% (95% CI: 12 -266%) of the total serum TG-elevating effects induced by PPD-Q exposure”

    Humansmediation of PPD-Q-induced serum triglyceride elevationn = 255

    Mitochondrial DNA copy number mediates PPD-Qs-induced lipid level alterations in humans

    Ecotoxicology and environmental safety

More on Mitochondrial DNA copy number

C-reactive protein

mediatesin humans1

1 study
  1. C-reactive protein is linked with triglyceride in humans (24.7% mediated (95% Monte Carlo CI 11.9% to 41.3%); inflammation-mediated triglyceride increase of 2.7% (95% CI 1.0% to 4.5%) per 5 kg/m2 BMI increment).

    “CRP mediated 24.7% (95% Monte Carlo CI: 11.9% to 41.3%) of the BMI-triglyceride association.”

    HumansStatistical mediation of the BMI-triglyceride association in adults with a history of smoking52.1% femalesn = 863

    The Population-Attributable Role of Systemic Inflammation in Obesity-Related Dyslipidemia: A Cross-Sectional Mediation Study of U.S. Adults with a History of Smoking

    Research SquarePreprint

More on C-reactive protein

APOB

no changein humans1

1 study
  1. APOB showed no clear effect on triglyceride in hypercholesterolemic adults treated with rosuvastatin 20 mg for 3 months (P = .751).

    “TG was not affected (P = .751)”

    Human trialin hypercholesterolemic adults treated with rosuvastatin 20 mg for 3 months3 monthsn = 79

    Preliminary Evidence for the Association of APOB rs1042034 With Short-Term Statin-Induced Lipid Lowering: An Exploratory Study in Vietnam

    Journal of cardiovascular pharmacology and therapeutics

More on APOB

Older-adults

upin humans1

1 study
  1. Older-adults increase triglyceride in humans following yoghurt challenge, compared with young adults.

    “Following the yoghurt challenge, OA exhibited significantly higher triglyceride iAUC than YA, with a trend towards higher values observed following the milk challenge.”

    Human trialfollowing yoghurt challenge, compared with young adults15 min

    Postprandial metabolic effects of milk and yoghurt in young and older adults

    Genes & nutrition

Physical activity energy expenditure

downin humans1

1 study
  1. Physical activity energy expenditure decreases triglyceride in humans (overweight) (P ≤ 0.022).

    “in participants who were overweight, higher PAEE was associated with lower triglyceride and triglyceride: high-density lipoprotein-cholesterol ratio (P ≤ 0.022)”

    Human trialoverweight24 months

    Association between physical activity energy expenditure and markers of healthspan during prolonged calorie restriction in individuals without obesity: observations from the CALERIE™ phase 2 randomized controlled trial

    The international journal of behavioral nutrition and physical activity

More on Physical activity energy expenditure

Normal weight obesity

upin humans1

1 study
  1. Normal weight obesity increases triglyceride in humans (4 h postprandial after high-fat meal) (239.4 ± 101.0 mg/dL).

    “NWO-O had higher 4 h triglycerides (239.4 ± 101.0 mg/dL) compared to NWL-Y and NWL-O (p < 0.01), consistent with an adverse response.”

    Human trial4 h postprandial after high-fat mealbloodn = 29

    Postprandial Cardiometabolic Parameters in Older Adults with Normal-Weight Obesity: A Cross-Sectional Pilot Study

    Metabolites

All 35

Associations

256

Sarcopenia

upin humans5downin humans2

7 studies
  1. Triglyceride is associated with sarcopenia in humans (Korean postmenopausal women; adjusted for age, BMI, and age at menopause) (aOR 1.051 per 10 mg/dL increase, 95% CI 1.020–1.072).

    “each 10 mg/dL increase in triglyceride levels was associated with approximately 5.1% higher odds of sarcopenia”

    HumansKorean postmenopausal women; adjusted for age, BMI, and age at menopauseeach 10 mg/dL increasefemalesn = 1,157

    Prevalence and Blood Biochemical Parameters Associated with Sarcopenia Among Korean Postmenopausal Women Aged 50 Years and Older: A Nationwide Cross-Sectional Study

    Healthcare (Basel, Switzerland)

  2. Triglyceride is linked with a lower risk of sarcopenia in humans.

    “An increase in triglyceride levels over four years was also associated with a reduced likelihood of possible sarcopenia.”

    Humans4 yearsfemalesn = 224

    Relationship Between Metabolic Syndrome Indicators Within Reference Ranges and Sarcopenia in Older Women-A 4-Year Longitudinal Study

    Geriatrics (Basel, Switzerland)

  3. Triglyceride is associated with sarcopenia in humans (p = 0.002).

    “Correlation analysis revealed a positive association between sarcopenia and BMI, insulin resistance, high triglyceride levels, and the presence of dyslipidaemia”

    Humansn = 135

    Are Hyperlipidaemia and Insulin Resistance Risks For Sarcopenia?

    Journal of the College of Physicians and Surgeons--Pakistan : JCPSP

  4. Triglyceride is linked with a higher risk of sarcopenia in humans (adjusted multiple logistic regression) (β = 1.475, 95% CI: 1.024-2.124).

    “blood triglycerides (β = 1.475, 95% CI: 1.024-2.124), as well as being a female (β = 0.086, 95%CI: 0.026-0.288) and having higher BMI (β = 0.908, 95%CI: 0.852-0.967) and ALM/BMI (β = 0.000, 95% CI: 0.000-0.007) are independent predictors (p < 0.05) of sarcopenia risk.”

    Humansadjusted multiple logistic regressionn = 767

    Risk and determinants of sarcopenia in people with diabetes: a case-control study from Qatar Biobank cohort

    BMC endocrine disorders

  5. Triglyceride is associated with sarcopenia in humans (Nonlinear, log-shaped association; cutoff 92.75 mg/dL).

    “Elevated TG, but not HDL-C, LDL-C, or TC levels, was significantly associated with an increased risk of sarcopenia (P for trend = 0.001).”

    HumansNonlinear, log-shaped association; cutoff 92.75 mg/dL

    The relationship between serum lipid with sarcopenia: Results from the NHANES 2011-2018 and bidirectional Mendelian randomization study

    Experimental gerontology

  6. Triglyceride is linked with a higher risk of sarcopenia in humans (p < 0.05).

    “fasting glucose and triglyceride levels were risk factors for sarcopenia (p < 0.05).”

    Humansmales

    A Korean Nationwide Cross-Sectional Study Investigating Risk Factors, Prevalence, and Characteristics of Sarcopenia in Men in Early Old Age

    Healthcare (Basel, Switzerland)

  7. Sarcopenia is associated with triglyceride in humans (sarcopenia).

    “Sarcopenia is characterized by lower serum triglycerides”

    Reviewsarcopenia

    Pathophysiological Mechanisms Underlying Sarcopenia and Sarcopenic Obesity: A Systematic Review and Meta-Analysis of Biomarker Evidence

    International journal of molecular sciences

More on Sarcopenia

Hypertension

upin humans5upin silico2OR 1.002–1.56

6 studies
  1. Triglyceride is associated with hypertension in humans (aOR = 1.84, 95% CI: 1.13-3.04).

    “elevated triglycerides were associated with diabetes (aOR = 2.16, 95% CI: 1.21-3.75) and hypertension (aOR = 1.84, 95% CI: 1.13-3.04).”

    Humans

    Prevalence and risk factors of cardiometabolic disease among informal sector workers in Cape Coast, Ghana: Insights from the CarMeR study

    PloS one

  2. Triglyceride is associated with hypertension in humans (OR: 1.002, 95% CI: 1.001-1.003).

    “significant positive association was observed between triglyceride levels and the prevalence of hypertension (OR: 1.002, 95% CI: 1.001-1.003; P < 0.001)”

    Humans

    Association and causality between triglycerides and hypertension: evidence from NHANES 2007-2018 and two-sample Mendelian randomisation analysis

    Cardiovascular journal of Africa

  3. Triglyceride is associated with hypertension in humans (adjusted OR 1.43, 95% CI 1.16-1.75).

    “Observational analyses showed a strong positive association between TG levels and hypertension (crude odds ratio [OR] = 2.12; 95% confidence interval [CI]: 1.76-2.54; adjusted OR = 1.43; 95% CI: 1.16-1.75).”

    Humansn = 2,159

    Triglycerides and Hypertension in a Korean Population: An Individual-Level Mendelian Randomization Analysis

    Nutrients

  4. Triglyceride is linked with a higher risk of hypertension in humans after full adjustment for age, gender, and BMI.

    “positive association between TG and RC ≥ 30 levels and HTN ([1.003(1.002-1.005), p < 0.001]; [1.36 (1.123-1.648), p:0.002], respectively).”

    Humansafter full adjustment for age, gender, and BMIn = 1,918

    Remnant cholesterol, not LDL cholesterol, is associated with the risk of hypertension in the middle-aged and elderly population: Bushehr Elderly Health cohort

    Frontiers in cardiovascular medicine

  5. Triglyceride is linked with a higher risk of hypertension in humans (OR 1.56, 95% CI 1.33-1.85, p < 0.001).

    “triglycerides (bl_tg), HDL (bl_hdl), and low-density lipoprotein LDL cholesterol were identified as significant risk factors, with odds ratios (ORs) of 1.56 (95% CI: 1.33-1.85, p < 0.001)”

    Humansn = 3,373

    Mediating Effects of Serum Lipids and Physical Activity on Hypertension Management of Urban Elderly Residents in China

    Metabolites

  6. Triglyceride raises the risk of hypertension in silico.

    “Mendelian randomisation (MR) analysis also supported a causal effect of elevated triglyceride levels on increased hypertension risk”

    In silico

    Association and causality between triglycerides and hypertension: evidence from NHANES 2007-2018 and two-sample Mendelian randomisation analysis

    Cardiovascular journal of Africa

  7. Triglyceride raises the risk of hypertension in silico (OR 1.262, 95% CI 1.129–1.411).

    “Furthermore, high triglyceride levels were identified as a risk factor for hypertension (OR [95% CI]: 1.262 [1.129, 1.411], p < 0.001).”

    In silico

    Causal Paradigm Between Common Comorbidities of Cardiovascular and Metabolism-Related Diseases in Elderly: Evidence from Cross-Sectional and Mendelian Randomization Studies

    Diabetes, metabolic syndrome and obesity : targets and therapy

More on Hypertension

Cognitive function

downin humans4upin humans2

6 studies
  1. Triglyceride is associated with cognitive function in humans (p = 0.011).

    “presence of carotid artery (CA) stenosis ( p = 0.01), smoking ( p = 0.005), reduced left ventricular ejection fraction ( p = 0.039), and high triglyceride levels ( p = 0.011) was associated with a cognitive decline”

    Humans5–7 yearsn = 146

    Risk factors for cognitive decline in patients in long-term period of coronary artery bypass grafting

    Bulletin of Siberian Medicine

  2. Cognitive function is associated with triglyceride in humans (beta -0.03, 95% CI -0.04 to -0.01, p < 0.001).

    “triglycerides (-0.03 [-0.04, -0.01]; <0.001)”

    Humans

    Cognitive function in childhood and cardiovascular disease risk factors up to 6 decades later: Pooled data from two birth cohort studies

    medRxiv : the preprint server for health sciencesPreprint

  3. Triglyceride is associated with cognitive function in individuals aged >34 years (r = -0.31, p = .041).

    “In individuals aged >34 years old, a negative correlation was observed between serum TG levels and MoCA scores (r = -0.31, p = .041).”

    Humansin individuals aged >34 years

    Age: A Moderating Effect on Cerebrospinal Fluid Fibroblast Growth Factor 21 and Cognitive Function

    Brain and behavior

  4. Triglyceride is associated with cognitive function in humans (β = -0.036, p < 0.001; β = -0.044, p < 0.001; β = 0.058, p = 0.001).

    “Conversely, triglyceride (TG) = 0.75∼8.0 mmol/L was positively correlated with cognitive function (β = -0.036, p < 0.001; β = -0.044, p < 0.001; β = 0.058, p = 0.001).”

    Humans0.75∼8.0 mmol/Ln = 26,394

    The necessity of strengthening glycemic and lipid metabolism management for improving brain structure and cognitive function in people with diabetes: A retrospective study based on UK Biobank

    Diabetes research and clinical practice

  5. Triglyceride is associated with cognitive function in humans.

    “higher TG levels were correlated with higher cognitive scores (P = 0.036)”

    Humans

    Association Between Serum Lipid Traits and Cognitive Function in Middle-aged and Elderly Adults: A Longitudinal Study

    Current Alzheimer research

  6. Triglyceride is associated with cognitive function in humans (stable and normal cognitive functions) (t(202) = 2.275, p values < 0.05).

    “individuals in the 1st decile of triglyceride changes and with stable and normal cognitive functions showed significant improvement in CASI scores compared to those in the 10th decile (t(202) = 2.275, p values < 0.05).”

    Humansstable and normal cognitive functions

    Non-linear relationship between serum cholesterol levels and cognitive change among older people in the preclinical and prodromal stages of dementia: a retrospective longitudinal study in Taiwan

    BMC geriatrics

Age-related macular degeneration

downin humans5OR 0.77–0.83

5 studies
  1. Triglyceride is linked with a lower risk of age-related macular degeneration in humans (OR 0.82, 95% CI 0.73-0.92, p = 0.001).

    “triglycerides (TG) (OR, 0.82; 95% CI, 0.73-0.92; p = 0.001) and high-density lipoprotein (HDL) (OR, 1.15; 95% CI, 1.04-1.28; p = 0.009) were significantly associated with early AMD”

    Humans

    The global disease burden and associated risk factors of age-related macular degeneration: a comprehensive analysis

    International ophthalmology

  2. Triglyceride is associated with age-related macular degeneration in humans (multivariate analysis) (OR 0.77, 95% CI 0.64-0.93).

    “and a lower triglyceride level (P = 0.008; OR, 0.77; 95% CI, 0.64-0.93).”

    Humansmultivariate analysis

    Five-Year Incidence of Age-Related Macular Degeneration and Its Risk Factors in Adult Chinese Population: The Tongren Health Care Study

    Translational vision science & technology

  3. Triglyceride is linked with a lower risk of age-related macular degeneration in humans (OR 0.83, p = 0.02).

    “triglycerides were found to mitigate the risk (p = 0.02, OR = 0.83)”

    Humans

    Causality of Diabetic Nephropathy and Age-Related Macular Degeneration: A Mendelian Randomization Study

    Gene

  4. Triglyceride is linked with a lower risk of age-related macular degeneration in humans.

    “higher levels of serum total triglycerides (TG) and several very-low-density lipoprotein subclass particles were associated with a decreased risk of AMD”

    Humansn = 6,947

    Relationships between Lipid-Related Metabolites and Age-Related Macular Degeneration Vary with Complement Genotype

    Ophthalmology science

  5. Triglyceride is linked with a lower risk of age-related macular degeneration in humans (genetically predicted levels (two-sample Mendelian randomization)).

    “Genetically predicted TG levels were associated with decreased risk of different AMD subtypes.”

    Humansgenetically predicted levels (two-sample Mendelian randomization)

    The effects of eight serum lipid biomarkers on age-related macular degeneration risk: a Mendelian randomization study

    International journal of epidemiology

More on Age-related macular degeneration

Gestational diabetes mellitus

upin humans4upin silico1OR 1.01–2.277

4 studies
  1. Triglyceride predicts gestational diabetes mellitus in humans (First-trimester measurement in singleton pregnancies) (AUC 0.687; >125 mg/dL cut-off: 62.69% sensitivity and 74.81% specificity).

    “Triglycerides demonstrated an AUC of 0.687; a cut-off of >125 mg/dL yielded 62.69% sensitivity and 74.81% specificity.”

    HumansFirst-trimester measurement in singleton pregnanciesserumfemalesn = 336

    First-Trimester Lipid Profile and Subsequent Gestational Diabetes Mellitus: A Retrospective Case–Control Study

    Metabolites

  2. Triglyceride is associated with gestational diabetes mellitus in humans (Singleton pregnancies; lipids measured between 11 + 0 and 13 + 6 weeks of gestation) (OR = 1.010, 95% CI: 1.005–1.014; p < 0.001).

    “Triglyceride concentration was significantly associated with GDM (OR = 1.010, 95% CI: 1.005–1.014; p < 0.001).”

    HumansSingleton pregnancies; lipids measured between 11 + 0 and 13 + 6 weeks of gestationserumfemalesn = 336

    First-Trimester Lipid Profile and Subsequent Gestational Diabetes Mellitus: A Retrospective Case–Control Study

    Metabolites

  3. Triglyceride is linked with a higher risk of gestational diabetes mellitus in pregnant women (P trend<0.01).

    “triglycerides (TG), lymphocyte count and glycated haemoglobin (HbA1c) were all associated with an increased risk of GDM (P trend<0.01).”

    Humansin pregnant womenn = 678

    Evaluation of the first trimester maternal glycolipid profile on gestational diabetes mellitus: a case-control study in the hospital of rural Shanghai

    BMJ open

  4. Triglyceride is linked with a higher risk of gestational diabetes mellitus in humans (early pregnancy (8-12 weeks)) (OR = 2.277).

    “HOMA-IR (OR = 3.287), TG (OR = 2.277), GWG-F (OR = 1.150)”

    Humansearly pregnancy (8-12 weeks)

    Early-pregnancy trunk phase angle derived from bioelectrical impedance analysis for the prediction of gestational diabetes mellitus

    Frontiers in endocrinology

  5. Triglyceride is linked with a higher risk of gestational diabetes mellitus in humans (early pregnancy case-control analysis) (OR = 1.27, 95% CI = 1.13-1.42).

    “TG (OR = 1.27, 95%CI=1.13-1.42, P < 0.05)”

    Humansearly pregnancy case-control analysisfemales

    Association between blood lipids, BMI and gestational diabetes mellitus in early pregnancy: a clinical study and Mendelian randomization

    Frontiers in endocrinology

  6. Gestational diabetes mellitus is associated with triglyceride in silico (reverse Mendelian randomization) (OR = 1.03, 95% CI = 1.02-1.04).

    “while the reverse MR analysis indicated that GDM may have an association effect on TG (OR = 1.03, 95%CI=1.02-1.04, P < 0.05)”

    In silicoreverse Mendelian randomizationfemales

    Association between blood lipids, BMI and gestational diabetes mellitus in early pregnancy: a clinical study and Mendelian randomization

    Frontiers in endocrinology

  7. Triglyceride is associated with gestational diabetes mellitus in silico (forward Mendelian randomization) (OR = 1.24, 95% CI = 1.10-1.40).

    “genetic evidence supported potential associations between TG (OR = 1.24, 95%CI=1.10-1.40, P < 0.05)”

    In silicoforward Mendelian randomizationfemales

    Association between blood lipids, BMI and gestational diabetes mellitus in early pregnancy: a clinical study and Mendelian randomization

    Frontiers in endocrinology

More on Gestational diabetes mellitus

Diabetes mellitus

upin humans4

4 studies
  1. Triglyceride is associated with diabetes mellitus in humans (aOR = 2.16, 95% CI: 1.21-3.75).

    “elevated triglycerides were associated with diabetes (aOR = 2.16, 95% CI: 1.21-3.75) and hypertension (aOR = 1.84, 95% CI: 1.13-3.04).”

    Humans

    Prevalence and risk factors of cardiometabolic disease among informal sector workers in Cape Coast, Ghana: Insights from the CarMeR study

    PloS one

  2. Triglyceride is associated with diabetes mellitus in humans (Adults living in El Trébol, Argentina).

    “DM was independently associated with older age, higher BMI, elevated triglycerides, lower HDL cholesterol, and insufficient physical activity.”

    HumansAdults living in El Trébol, Argentinan = 860

    Prevalence of Diabetes Mellitus and Cardiovascular Risk Factors in El Trébol, Argentina: A Population-Based Cross-Sectional Study

    Diabetology

  3. Triglyceride is linked with a higher risk of diabetes mellitus in humans (multivariable logistic regression).

    “Logistic regression analysis revealed that elevated triglyceride (TG) and reduced high-density lipoprotein cholesterol (HDL-C) were independent risk factors for diabetes.”

    Humansmultivariable logistic regression

    Evaluation of Urine Exosome Lecithin Cholesterol Acyltransferase as a Biomarker for Diabetes Diagnosis and Dyslipidemia

    Diabetes/metabolism research and reviews

  4. Triglyceride is associated with diabetes mellitus in Hainan centenarians.

    “Increased triglyceride level and abdominal obesity might be associated with the risk for diabetes.”

    Humansin Hainan centenariansn = 1,002

    Prevalence of diabetes and associated factors in Hainan centenarians

    Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi

More on Diabetes mellitus

C-reactive protein

upin humans3downin humans1

4 studies
  1. C-reactive protein is associated with triglyceride in humans (changes over six months of blackcurrant anthocyanin supplementation) (positive correlation; p < 0.01).

    “C-reactive protein (hs-CRP) change was positively correlated with changes in TG and IL-1β (p < 0.01).”

    Human trialchanges over six months of blackcurrant anthocyanin supplementationanthocyanin extractsix monthsfemalesn = 38

    Blackcurrant Anthocyanins Improve Blood Lipids and Biomarkers of Inflammation and Oxidative Stress in Healthy Women in Menopause Transition without Changing Body Composition

    Biomedicines

  2. C-reactive protein is associated with triglyceride in humans (dyslipidemia).

    “significant associations were also observed between hs-CRP and triglycerides (TG), as well as between hs-CRP and LDL-cholesterol (LDL-C) in premenopausal women with dyslipidemia.”

    Humansdyslipidemiafemales

    Association of high sensitive C-reactive protein and lipid markers in predicting atherosclerotic cardiovascular risk in dyslipidemic women

    Current Issues in Pharmacy and Medical Sciences

  3. Triglyceride is associated with C-reactive protein in humans (metabolic syndrome) (aOR 1.39; 95% CI 1.06–1.82; p = 0.018).

    “triglycerides (aOR 1.39; 95% CI 1.06–1.82; p = 0.018)”

    Humansmetabolic syndromen = 267

    Elevated High-Sensitivity C-Reactive Protein in Metabolic Syndrome: A Cross-Sectional Analytical Study at Islamabad

    Research SquarePreprint

  4. C-reactive protein is associated with triglyceride in humans (Menopausal women with hot flashes) (r = -0.189, P = 0.039).

    “hs-CRP negatively correlated with TG (r = -0.189, P = 0.039) and TC/HDL-C (r = -0.268, P = 0.003) in menopausal women with HFs.”

    HumansMenopausal women with hot flashesfemalesn = 120

    Interleukin-17, C-reactive protein, Neutrophil-to-Lymphocyte ratio, Lymphocyte-to-Monocyte ratio, and lipid profiles in healthy menopausal women with or without hot flashes: A cross-sectional study

    PloS one

More on C-reactive protein

Osteoporosis

upin humans2downin humans1mixedin rats1OR 2.5

4 studies
  1. Triglyceride is associated with osteoporosis in humans.

    “elevated triglyceride, total cholesterol, and LDL levels were positively associated with osteoporosis”

    Humans

    Association between osteoporosis and cardiovascular disease in elderly people: evidence from a retrospective study

    PeerJ

  2. Triglyceride is associated with osteoporosis in humans (OR 2.50, 95% CI 1.13-5.51).

    “The adjusted odds ratio of logarithmic triglyceride level for osteoporosis was 2.50 (95% confidence interval 1.13-5.51) in women older than 65 years.”

    Humansfemales

    Bone mineral density and lipid profiles in older adults: a nationwide cross-sectional study

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA

  3. Osteoporosis is associated with triglyceride in humans.

    “BMI and TG levels were significantly decreased in osteoporotic patients compared with normal bone mass patients.”

    Humans

    Weight loss in elderly orthopaedic patients leads to bone loss

    Research SquarePreprint

  4. Triglyceride is associated with osteoporosis in rats (association in aging and ovariectomized rats, but not diabetic rats).

    “was also identified to be closely associated with OP in aging and OVX rats, but not in diabetic rats.”

    Animalsassociation in aging and ovariectomized rats, but not diabetic ratscortical bone

    Osteoporosis with different causation exhibits different changes in bone tissue mineral and organic matrix

    bioRxiv (Cold Spring Harbor Laboratory)Preprint

More on Osteoporosis

Metabolic syndrome

upin humans3OR 1.01

3 studies
  1. Triglyceride predicts metabolic syndrome in humans (Cross-sectional discrimination in overweight and obese outpatients) (AUC 0.852; sensitivity 100%).

    “triglycerides (area under the curve [AUC]=0.852), visceral fat index (AUC=0.790), and diastolic blood pressure (AUC=0.693) had significant predictive efficacy for MetS.”

    HumansCross-sectional discrimination in overweight and obese outpatientsn = 121

    Body Composition and Its Predictive Value for Metabolic Syndrome Risk in Overweight and Obese Populations

    Research SquarePreprint

  2. Triglyceride is associated with metabolic syndrome in humans (at-risk adults) (p < 0.05).

    “as well as abnormal FBS and elevated triglyceride levels (all p < 0.05)”

    Humansat-risk adultsn = 1,781

    Evaluation of the effect of baseline predictors on the incidence of metabolic syndrome in middle-aged and elderly individuals: a population-based cohort study in Southwest Iran

    Diabetology & metabolic syndrome

  3. Triglyceride is associated with metabolic syndrome in humans (OR: 1.01; 95% CI 1.01-1.02).

    “followed by TG levels (OR: 1.01; 95% CI 1.01-1.02).”

    Humansn = 1,918

    Association between Remnant Cholesterol and Metabolic Syndrome beyond Conventional Lipid Parameters in Middle Age and Elderly Population: Bushehr Elderly Health (BEH) cohort

    Journal of diabetes and metabolic disorders

More on Metabolic syndrome

Mortality

upin humans2mixedin humans1HR 1.02–1.464

3 studies
  1. Triglyceride is associated with mortality in humans (Patients with coronary heart disease undergoing PCI; multivariable-adjusted analysis) (Non-significant U-shaped association; P=0.1965).

    “shifting to a non-significant U-shaped pattern after multivariable adjustment (P=0.1965).”

    HumansPatients with coronary heart disease undergoing PCI; multivariable-adjusted analysis10-year follow-up83% malesn = 4,304

    Genetic modifiers of triglyceride-mediated mortality in coronary heart disease: a large cohort study of polygenic risk and circulating triglyceride level interaction

    ESC Congress 2026 abstract

  2. Triglyceride is linked with a higher risk of mortality in males, highest quartile (HR: 1.464, p=0.008).

    “highest triglyceride quartile independently predicted mortality only in males (HR: 1.464, p=0.008)”

    Humansin males, highest quartilemales

    Impact of lipid profiles and risk factors on all-cause mortality in males and females: insights from a Turkish cohort study

    Open medicine (Warsaw, Poland)

  3. Triglyceride is linked with a higher risk of mortality in humans (HRs: 1.02-1.25 per SD).

    “In contrast, positives were observed for HDL (large/very large) and triglyceride concentrations [HRs: 1.02-1.25 per SD], indicating increased mortality risk with higher levels.”

    Humans17-year follow-upn = 441,448

    Systematic analysis of relationships between serum lipids with all-cause and cause-specific mortality: Evidence from prospective cohort studies of UK Biobank and Women's Health Initiative

    Clinical nutrition (Edinburgh, Scotland)

Adiposity

upin humans2

2 studies
  1. Triglyceride is associated with adiposity in humans (obese older adults).

    “decreased triglyceride (TG) (16:1/18:1/16:0) and aspartic acid significantly correlated with a reduction of adiposity-related parameters”

    Human trialobese older adults

    Serum metabolomic adaptations following a 12-week high-intensity interval training combined to citrulline supplementation in obese older adults

    European journal of sport science

  2. adiposity is associated with triglyceride in humans (chronic spinal cord injury) (r = 0.31, p < 0.05).

    “serum triglycerides (r = 0.31, p < 0.05)”

    Humanschronic spinal cord injuryn = 62

    Obesity in chronic spinal cord injury is associated with poorer body composition and increased risk of cardiometabolic disease

    Scientific reports

Protein intake

downin humans1

1 study
  1. Protein intake predicts triglyceride in humans (higher relative daily protein intake during caloric restriction).

    “higher relative daily protein intake independently predicted greater triglyceride reductions (p = 0.042)”

    Human trialhigher relative daily protein intake during caloric restriction12 weeksfemalesn = 26

    Changes in Total and Regional Body Composition Are Not the Primary Predictors of Metabolic Improvements Following Caloric Restriction in Females with Overweight or Obesity

    Frontiers in nutrition

More on Protein intake

Discordance among routine LDL cholesterol reporting methods

upin humans1

1 study
  1. Triglyceride is associated with discordance among routine LDL cholesterol reporting methods in humans during postprandial lipemia.

    “Concordance between calculated LDL-C and LDL-CCM declined as triglycerides increased and was lowest after oral fat loading.”

    Human trialduring postprandial lipemian = 62

    Triglyceride-dependent discordance in routine LDL cholesterol reporting during postprandial lipaemia: a self-controlled repeated-measures study

    Scandinavian journal of clinical and laboratory investigation

Muscle mass

downin humans1OR 0.21

1 study
  1. Triglyceride predicts muscle mass in humans (OR = 0.21, CI 0.04-1.03, p = 0.05).

    “triglycerides appeared as a borderline negative predictor (OR = 0.21, CI 0.04-1.03, p = 0.05)”

    Human trialin patients with type 2 diabetes with sarcopenic obesity and MASLD treated with HMB supplement6 monthsn = 48

    Observation of the impact of nutritional support with beta-hydroxy-beta-methylbutyrate on lean mass parameters of body composition in patients with obesity, type 2 diabetes mellitus and metabolically associated fatty liver disease

    Orvosi hetilap

Glycolysis factor score

downin humans1

1 study
  1. Glycolysis factor score is associated with triglyceride in LT+TRT group (r=-0.52, P = 0.01).

    “and inversely correlated with triglycerides (r=-0.52, P = 0.01) and the metabolic syndrome score (r=-0.48, p = 0.02).”

    Human trialin LT+TRT groupskeletal muscle26 weeksmales

    Testosterone plus lifestyle therapy improves skeletal muscle glycolysis in older men with obesity and hypogonadism

    Frontiers in endocrinology

More on Glycolysis factor score

All 256

Funding

5 grants since 2018

National Institute of Diabetes and Digestive and Kidney Diseases$2.4MNational Institute on Aging$131KJapan Society for the Promotion of Science¥8.1M

How this record changed

  1. Summary rewritten as its findings changed.

    As it read before

    Higher triglycerides are linked with incident frailty in a human cohort preprint and sarcopenia in Korean postmenopausal women; higher cumulative levels are associated with greater GrimAge acceleration in humans. Human trials report triglyceride reductions with exercise, whole grains, and caloric restriction, but increases with a high-carbohydrate diet.

  2. Summary rewritten as its findings changed.

    As it read before

    Higher triglycerides are associated with incident frailty in a human cohort preprint and low relative muscle mass in a human study. Another human study links triglycerides to epigenetic age. Human trials report triglyceride reductions with exercise, dietary changes, fish oil, and several drugs.

  3. Summary rewritten as its findings changed.

    As it read before

    Higher triglycerides associate with incident frailty in a human cohort preprint, lower relative muscle mass in a human study, and greater GrimAge acceleration in humans. Human trials report triglyceride reductions with fish oil, while acarbose and resveratrol show reductions or no change across different treatment settings.

  4. Summary rewritten as its findings changed.

    As it read before

    Human studies associate triglycerides with mortality in men, low relative muscle mass and vascular markers. Human trials report triglyceride reductions with exercise, dietary changes and several drugs, but a resistance-training trial reports no change during pregnancy.

  5. Summary rewritten as its findings changed.

    As it read before

    Human studies associate triglycerides with hypertension and gestational diabetes; human trials report reductions with exercise and dietary interventions. A human study links sarcopenic obesity to lower triglycerides than simple obesity, while another reports higher triglycerides in frail older adults with diabetes. Reviews describe both reductions and no change with exercise.

Latest

See all 6,469 papers on triglyceride